SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-025266
Filing Date
2017-05-08
Accepted
2017-05-08 16:50:18
Documents
10
Period of Report
2017-05-04
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v466109_8k.htm 8-K 91216
2 EXHIBIT 3.1 v466109_ex3-1.htm EX-3.1 8520
3 EXHIBIT 3.2 v466109_ex3-2.htm EX-3.2 6339
4 EXHIBIT 3.3 v466109_ex3-3.htm EX-3.3 127805
5 EXHIBIT 10.1 v466109_ex10-1.htm EX-10.1 300941
6 EXHIBIT 10.2 v466109_ex10-2.htm EX-10.2 41977
7 EXHIBIT 10.3 v466109_ex10-3.htm EX-10.3 43075
8 EXHIBIT 16.1 v466109_ex16-1.htm EX-16.1 2598
9 EXHIBIT 99.1 v466109_ex99-1.htm EX-99.1 12772
10 GRAPHIC image_001.jpg GRAPHIC 12641
  Complete submission text file 0001144204-17-025266.txt   654717
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 17823098
SIC: 2834 Pharmaceutical Preparations